Skip to content

comparison between a bladder sparing approach and a radical cystectomy in patients with a non-metastasized muscle invasive bladder carcinoma

Effectivity of a bladder sparing treatment (by chemoradiation or brachytherapy) in comparison to a radical cystectomy in patients with a non-metastasized T2-4aN0M0 muscle invasive bladder carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON25055
Enrollment
1000
Registered
2018-07-13
Start date
2018-11-25
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blaaskanker, spierinvasief bladder cancer, muscle invasive

Interventions

None listed

Sponsors

Amsterdam UMC, AMC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: muscle invasive urothelial cell carcinoma of the bladder T2-4aN0M0 curative intend

Exclusion criteria

Exclusion criteria: No previous RT multifocal disease

Design outcomes

Primary

MeasureTime frame
Disease free survival

Secondary

MeasureTime frame
toxicity costs bladder preservation rate Qol

Contacts

Public ContactM.C.C.M. Hulshof

Dept of Radiotherapy Meibergdreef 9

m.c.hulshof@amc.nl+31 (0)20 5664231

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)